gel-e Life Sciences has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to natural biopolymers, gel-e’s patented approach provides rapid hemostasis in a clean, safe healing environment. Using non-dilutive grant funding, the company has achieved milestones such as 1 FDA Clearance, 5 issued patents, and 6 peer-reviewed publications.